Nature Medicine
·
August 14, 2026
An AI-Health infrastructure for the Nordic region: technical foundations, data assets, and a roadmap for deployment.
Lappalainen Lab
Tuuli Lappalainen’s lab studies functional genetic variation in human populations. It is particularly interested in regulatory variation affecting the transcriptome, as well as cellular mechanisms underlying genetic associations to disease. The lab integrates computational analysis of genomic and transcriptomic data with population genetic and experimental analysis.
Tuuli Lappalainen, PhD
Senior Associate Faculty Member, NYGC
Director, National Genomics Infrastructure, SciLifeLab; Professor, KTH School of Engineering Sciences in Chemistry, Biotechnology and Health; Former Assistant Professor, Department of Systems Biology, Columbia University
Latest News & Publications
-
-
medRxiv · July 31, 2026 · Preprint
Systematic Integration of genomics with transcriptomics for the Study of Coronary Artery Disease and Subclinical Atherosclerosis.
-
bioRxiv · July 10, 2026 · Preprint
Isoform-level resolution in single-cell CRISPR screens reveals hidden functional consequences of gene perturbation.
Biology, Genomics & Technology 
Support The Lappalainen Lab
To support our work, please click below and specify ‘The Lappalainen Lab’ in the designation field.
